Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis

Fig. 4

Forest plot for meta-analysis and subgroup analysis according to EF(A), type of SGLT2i(B) and age(C), comparing the effects of SGLT2i with PBO in KCCQ-CS score KCCQ-CS score increase ≥ 5 points(D). SGLT2i, SGLT-2 inhibitor, PBO, placebo, Effect stands for WMD = Weighted Mean Difference, CI confidence interval, RR = risk ratio

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840